Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India-Style Patent Laws Targeted In Trans-Pacific Trade Negotiations

This article was originally published in The Pink Sheet Daily

Executive Summary

Draft intellectual property chapter of the Trans-Pacific Partnership includes a provision prohibiting signatories from denying patents solely because a product did not show enhanced efficacy over a known product.

You may also be interested in...

Trade Deal Looking Worse For Pharma As More Details Emerge

Trans-Pacific Partnership excludes patent linkage, evergreening provisions that industry had sought in addition to 12 years for biologics data exclusivity, which got knocked back to eight years.

Biosimilars Provision In Pacific Trade Deal Adds Fuel To Generic Fight

As negotiations over Trans-Pacific Partnership Agreement near completion, generic drug advocates make all-out push to eliminate IP provisions, particularly one they say would create patent linkage for biologics.

WikiLeaks Releases Draft Patent Chapter Of Trans-Pacific Free Trade Pact

The draft text highlights some key disagreements on intellectually property law questions between countries negotiating the comprehensive Trans-Pacific Partnership free trade agreement, including those related to method patents.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts